MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE

Similar documents
INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR REGENERATIVE MEDICINE

Harvard Stem Cell Institute

ORACLE OTTAWA REGION FOR ADVANCED CARDIOVASCULAR RESEARCH EXCELLENCE STRATEGIC DIRECTIONS

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

The Endocrine Society Strategic Plan 2011 (Approved by Council on June 2, 2011) Strategic Plan Overview

Improve your probability. of success

Chairman Cole, Ranking Member DeLauro and distinguished members of the

Pioneering Clinical Omics

social, and population-based research conducted and supported by the National Institutes of Health (NIH). The

CCTG initiative. patient reported outcomes (including wearables)

Innovation and Technology in Breast Cancer 2019 A research initiative from Breast Cancer Foundation NZ.

THE CAMPAIGN FOR UC SANTA CRUZ THE GENOMICS INSTITUTE

Personalized. Health in Canada

Roche in Australia Innovation Leader

Employment in the biopharma industry grew almost 5 percent in 2014, the last full year for which we have data. This is the highest annual growth rate

The Power to Cure: Therapeutic Innovation in Academia

MONASH BIOMEDICINE DISCOVERY INSTITUTE. At a Glance. monash.edu/discovery-institute

Artificial Intelligence in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle

US Food and Drug Administration. Sandra L. Kweder, MD Deputy Director, Europe Office

OME 2013 summary of pitches

Delivering on the Promise of Precision Medicine

Illustration inspired by the work of John Maynard Keynes Springer Nature Nano/AdisInsight. Daria Iovcheva November, 2017

Up Close and Personal

Working Together for Better Health Partnering with Boehringer Ingelheim. JOURNEE COLLABORATIVE DE LYONBIOPOLE October 10, 2017

THERAPEUTIC AREAS CARDIOVASCULAR RESEARCH

On behalf of the Cystic Fibrosis Foundation (CFF) and the 30,000 people with cystic

A bold vision for 2025

The Integrated Biomedical Sciences Graduate Program

The Role of the NIH Clinical Center in Translational and Clinical Research

Innovation and Technology in Breast Cancer 2018 A research initiative from Breast Cancer Foundation NZ.

IMI2: Strategic research agenda and overall approach Hugh Laverty Senior Scientific Project Manager

ADVANCE MEDICINE. AstraZeneca Japan President Stefan Woxström shares his healthcare vision. By C Bryan Jones

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University

building better science

Cardinal Health Specialty Solutions. Bringing a new drug to life. Regulatory Sciences

Strategic Plan. Uniting to care & cure

Konica Minolta and INCJ Agree to Acquire Ambry Genetics in a Deal Valued at US$1 billion

E&T objectives in evolving pharma business models. Magda Chlebus Director Science Policy Brussels, 2 March 2015

Computational Biology

FDA Critical Path Initiative: Closing Productivity Gap in Medical Product Development. October 4, 2004

BRIDGING THE GAP BETWEEN MEDICAL DISCOVERIES AND IMPROVED HEALTH AUSTRALIA TRANSLATIONAL RESEARCH INSTITUTE.

Science Education & Communication. Dennis A. Ausiello, MD President Association of American Physicians

Stands for purpose. Molecular Horizons: Centre for Molecular & Life Sciences

A CLOSER LOOK GBL/COR/0916/1075 U.S

Clinical and Translational Research: Expectations and Goals

GUIDE HEA

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

Strategy 4 Selection 4 Development 4 Succession Management

CRO partner in Rx/CDx Co-Development

Translational Research through Public-Private Partnerships. 65 th Annual Bohan Lecture. Scott J. Weir, PharmD, PhD 08 October 2011

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms

Smarter Healthcare across the Lifecycle with Analytics

Virtual tests for new therapies

Personalized Human Genome Sequencing

Strategic Plan. Uniting to care & cure

Education Critical to Stem Cell Therapy Pipeline

UAMS ADVANCED DIAGNOSTICS FOR ADVANCING CURE

Lead the way. Molecular Imaging. GE Healthcare. imagination at work

HELPING DELIVER LIFE-CHANGING THERAPIES HEMATOLOGY ONCOLOGY

Changing the Practice of Medicine. The Novartis Institutes for BioMedical Research

Konica Minolta to Acquire Invicro (US)

Investing in Rare Disease Patient Advocacy Groups

Our website:

BIOTECHNOLOGY CENTER FOR A NEWYORK STATE CENTER FOR ADVANCED TECHNOLOGY

Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre

Drug Reposition & Open Innovation Initiatives: potential paths to new therapies and advancing medical science

Supporting efficient and effective clinical research in the UK

What is biomedical science?

Vertex and Moderna Establish Exclusive Collaboration to Discover and Develop mrna Therapeutics for Cystic Fibrosis

Protein research and bioinformatics

Innovative Medicines Initiative

I believe that the contributions of animal research to medical science are undeniable.

GSK R&D. Dr Ashley Bates Discovery Research GlaxoSmithKline Australia. Greenford (UK) Harlow (UK) Stevenage (UK) Verona (ITA) RTP (USA) Tokyo (JPN)

Working together for better health. Partnering with Boehringer Ingelheim

A unique Collaborative Model for the Discovery of New Therapeutic Approaches

Animal Research: The Benefits Outweigh the Costs. Alexis Miller. Loras College

Robert J. Beall, PhD, President and Chief Executive Officer Cystic Fibrosis Foundation

Following text taken from Suresh Kumar. Bioinformatics Web - Comprehensive educational resource on Bioinformatics. 6th May.2005

Strategic Plan. Prepared by Onco Research July Version 3.1

Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association

Achieving Mayo s s Value Equation: The Role of Systems and Procedures


The Healing Power of Data

About Clinical Trials: What They Can Mean For You?

About ICarbonX. Learn more:

People Powered Medicine

Innovations in Biomedical Engineering Education in Europe. Ratko Magjarević

Bioinformatics Institute

Bringing Home the Genome: the FDA s Role in Realizing Personalized Medicine Margaret Hamburg, M.D., FDA Commissioner

Inaugural Fraunhofer Delaware Technology Summit

Information Technology for Genetic and Genomic Based Personalized Medicine. Submitted. April 23, 2008

We've all heard the dismal statistics: 10,000 known diseases with only 500 treatments. Not great odds if you're a patient.

Imaging not only apoptosis. 30 October 2018 AusBiotech Australia Biotech Invest & Partnering 2018 Dr Barbara Meurer Chief Executive Officer

Welcome all. Principles of Tissue Engineering AMME4971 & AMME5971. Convenor: Professor Hala Zreiqat

Belgium, a European leader in clinical trials

LETI-HEALTH. Adrienne Pervès Deputy Director LETI Technologies for Biology and healthcare Department

First Place Essay. Katie P.

Innovation in medical devices as response to Europe's healthcare challenges. Industry's viewpoint

The Innovative Medicines Initiative Europe s partnership for health. Tek-Ang LIM, 20 June 2018, Brussels

DEFINING A NEW ERA IN DIGESTIVE DISEASE CARE

Transcription:

MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE

THE RESEARCH WE DO TODAY WILL DETERMINE THE TYPE OF MEDICAL AND SURGICAL PRACTICE WE CARRY ON AT THE CLINIC TOMORROW. -WILLIAM J. MAYO, M.D.

LEADING THROUGH DISCOVERY In medical practice, we provide the best choice of treatment based on current knowledge. Unfortunately, we do not always have a full understanding of the root causes of disease or the mechanisms that drive the treatments provided. At Mayo Clinic, we re assembling expert, state-of-the-art biomedical research teams to define the cellular and molecular basis of disease. We can summarize these mechanisms as the essence of disease. Our research teams create a core scientific knowledge that will drive the diagnostics, treatments and cures of tomorrow to provide the best care for you and your family. By understanding the essence of disease, we can work towards stopping it in its tracks, preventing it with greater success or eradicating it with greater precision. The discoveries needed to make those advances require nimbleness, passion and a diversity of approaches. This is possible at Mayo Clinic as we align scientists who have an extraordinary depth and breadth of world-class scientific expertise with their clinical colleagues. The Center for Biomedical Discovery provides a critical starting point for these efforts to solve our most pressing public health issues in ways that haven t previously been considered. The possibilities for discovery have never been greater, and the work involved has never been more complex. Multidisciplinary team science is needed now more than ever. The Center for Biomedical Discovery has the expertise to provide the foundation for medicine that understands the human body and how it works at a fundamental, molecular and cellular level to give you exactly the care you need. YOUR PARTNERSHIP ACCELERATES MAYO CLINIC S EFFORTS TO DEVELOP, REFINE AND IMPROVE NEW WAYS TO TREAT PATIENTS HELPING ANSWER THE WHY AND HOW OF DISEASE.

A DISTINCTIVE, TEAM-BASED STRATEGY TO CURE DISEASE Many biomedical research centers offer expertise in isolated aspects of biotechnology and patient care, but often these approaches are unconnected or disorganized, and lack focus. The Center for Biomedical Discovery takes a different approach by assembling comprehensive, multidisciplinary teams of exceptional scientists, engineers, technicians, geneticists and physicians to understand and treat disease. This team approach draws from our many strengths and has yielded important outcomes in a more efficient and rapid manner. The Center for Biomedical Discovery is leveraging Mayo Clinic s world-class biomedical research faculty, technology and infrastructure in addition to our gold standard of patient care to take a distinctive approach: Creating multidisciplinary teams of experts that are custom-made to solve the most complex and consequential problems just like we do with patient care. Understanding the basic mechanisms leading to diseases that afflict all organs by focusing on fundamental questions. These include how disease arises as a result of defects in cell aging, fibrosis (scarring), metabolism (alterations in body chemistry), obesity, inflammation, immunity (body s resistance to assault from inside or outside the body) and cell growth (as in tumors). Developing new drugs, therapies, and devices based on an understanding of the molecular and cellular essence of disease to provide more effective treatment. Synergizing with Mayo Clinic s leaders in research and care delivery to exchange ideas and information that will enhance personalized care.

COMPREHENSIVE TEAMS OF EXCEPTIONAL SCIENTISTS, ENGINEERS, TECHNICIANS, GENETICISTS AND PHYSICIANS WORK TOGETHER TO UNDERSTAND AND TREAT DISEASE FROM MULTIPLE DIRECTIONS, FORMING ROADMAPS THAT LEAD TO ANSWERS AND BREAKTHROUGH DISCOVERIES.

STARVING CANCER CELLS TO DEATH: MAYO RESEARCH TEAM WORKS TO CUT OFF THE ENERGY SUPPLY USED BY MOST TUMORS OBESITY IS MORE THAN SKIN DEEP: UNLOCKING THE MECHANISMS OF METABOLISM Our evolution as humans, diet and environment impact how we use and store the calories we consume. The Western diet appears to be exploiting a preference in human biology for the conservation of energy in times of plenty. This is leading to accelerated rates of obesity with higher incidence of fatty liver, diabetes and heart disease at an earlier age. The sobering reality is that today s younger generation may not live as long as their parents if this trend continues unchecked. We are beginning to unlock the mechanisms of cellular metabolism that drive the acceleration of obesity-related diseases and develop new approaches to prevent and treat diseases that affect so many of us at all ages. Where do tumor cells get the energy to divide non-stop while moving and invading other organs? This is an important question, and a team of Mayo Clinic discovery scientists is working to understand how tumor cells generate so much energy to grow and metastasize. Importantly, their new insights have led to the uncovering of new metabolic pathways. Drugs in clinical trials are aimed at disrupting these pathways in breast and pancreatic cancers. These therapies have led to promising results toward literally starving cancer cells to death.

YOUR SUPPORT CAN MAKE PATIENT-INSPIRED INNOVATION HAPPEN EVEN FASTER. JUST ONE PERSON CAN SPARK AN INNOVATION THAT TOUCHES MILLIONS OF LIVES.

ABOUT THE CENTER FOR BIOMEDICAL DISCOVERY AND THE FOCUS ON TEAM SCIENCE Mayo Clinic launched the Center for Biomedical Discovery to initiate and accelerate team science with the greatest promise to make the biggest impact on the largest number of patients. By focusing on the molecular and cellular basis of disease, the center seeks to understand abnormal processes that span all organ systems leading to most human diseases. Excellence in team-based science provides the foundation for excellence in team-based medicine. Thus, the Center for Biomedical Discovery provides an extraordinary opportunity to strengthen and advance what Mayo Clinic offers to patients as a global destination for complex care. MC7405